September 10, 2025Nanoscale AdvancesOpen Access

Nanomedicine Breakthroughs Overcoming Pancreatic Cancer Drug Resistance through Precision Nano-Interventions

View Full Paper

Ask AI

Bookmark

Authors

Discussion

This review reveals cutting-edge nanomedicine strategies that enhance drug delivery in pancreatic cancer, suggesting improved therapeutic outcomes.

Nanomedicine strategies enhance drug accumulation in pancreatic cancer cells, thereby reducing drug resistance and systemic toxicity.
The review highlights innovative nanocarriers that are stimuli-responsive, improving specificity and effectiveness in delivering chemotherapy.
Mechanistic insights show how these interventions bypass traditional drug resistance pathways, such as enhancing intracellular drug delivery.
Active targeting strategies increase selective delivery to therapy-resistant cancer stem cells, potentially improving treatment outcomes.

Peng et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

This review reveals cutting-edge nanomedicine strategies that enhance drug delivery in pancreatic cancer, suggesting improved therapeutic outcomes.